MedPath

BALMINIL NASAL OINTMENT

BALMINIL NASAL OINTMENT

Discontinued
DIN Number

02135639

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

rougier pharma division of ratiopharm inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02135639
AIG Number0526950002
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
R01AB05 EPHEDRINE
Product Specifications
Dosage FormOintment
Route of AdministrationNasal
AHFS Classification12:12.00
Health Canada Classification

ACTIVE INGREDIENTS (5)

CAMPHORActive
Strength: 4 MG / G
Monograph: CAMPHOR
CHLOROBUTANOLActive
Strength: 2 MG / G
Monograph: CHLOROBUTANOL
EPHEDRINE HYDROCHLORIDEActive
Strength: 6 MG / G
Monograph: EPHEDRINE HYDROCHLORIDE
EUCALYPTOLActive
Strength: 6 MG / G
Monograph: EUCALYPTOL
LEVOMENTHOLActive
Strength: 4 MG / G
Monograph: LEVOMENTHOL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.